Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 160.67 USD -0.09%
Market Cap: 9B USD

Wall Street
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 191.72 USD with a low forecast of 161.6 USD and a high forecast of 231 USD.

Lowest
Price Target
161.6 USD
1% Upside
Average
Price Target
191.72 USD
19% Upside
Highest
Price Target
231 USD
44% Upside
Repligen Corp Competitors:
Price Targets
MEDP
Medpace Holdings Inc
1% Upside
QGEN
Qiagen NV
13% Upside
MRVI
Maravai LifeSciences Holdings Inc
7% Upside
CDXS
Codexis Inc
260% Upside
2269
WuXi Biologics (Cayman) Inc
20% Upside
TECH
Bio-Techne Corp
20% Upside
NANOFH
Nanoform Finland Oyj
197% Upside
SHC
Sotera Health Co
16% Upside

Revenue
Forecast

Revenue Estimate
Repligen Corp

For the last 12 years the compound annual growth rate for Repligen Corp's revenue is 21%. The projected CAGR for the next 3 years is 15%.

21%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Repligen Corp

For the last 12 years the compound annual growth rate for Repligen Corp's operating income is 0%. The projected CAGR for the next 3 years is 142%.

0%
Past Growth
142%
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Net Income
Forecast

Net Income Estimate
Repligen Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGEN's stock price target?
Price Target
191.72 USD

According to Wall Street analysts, the average 1-year price target for RGEN is 191.72 USD with a low forecast of 161.6 USD and a high forecast of 231 USD.

What is Repligen Corp's Revenue forecast?
Projected CAGR
15%

For the last 12 years the compound annual growth rate for Repligen Corp's revenue is 21%. The projected CAGR for the next 3 years is 15%.

What is Repligen Corp's Operating Income forecast?
Projected CAGR
142%

For the last 12 years the compound annual growth rate for Repligen Corp's operating income is 0%. The projected CAGR for the next 3 years is 142%.

Back to Top